Monoallelically Expressed Gene Related to p53 at 1p36, a Region Frequently Deleted in Neuroblastoma and Other Human Cancers

Cell - Tập 90 Số 4 - Trang 809-819 - 1997
Mourad Kaghad1, H Bonnet, Annie Yang, Laurent Créancier, J C Biscan, A Valent, A Minty, P Chalon, Jean-Michel Lélias, Xavier Dumont, Patrizia Ferrara, Frank McKeon, Daniel Caput
1Sanofi Recherche, Labege, France.

Tóm tắt

Từ khóa


Tài liệu tham khảo

Ambros, 1995, Regression and progression in neuroblastoma. Does genetics predict tumour behaviour?, Eur. J. Cancer, 31A, 510, 10.1016/0959-8049(95)00044-J

Amler, 1995, Reciprocal translocation at 1p36.2/D1S160 in a neuroblastoma cell line, Eur. J. Cancer, 31A, 527, 10.1016/0959-8049(95)00064-P

Baker, 1990, Suppression of human colorectal carcinoma cell growth by wild-type p53, Science, 249, 912, 10.1126/science.2144057

Balaban, 1986, Karyotypic evolution in human malignant melanoma, Can. Genet. Cytogenet., 19, 113, 10.1016/0165-4608(86)90378-X

Ballester, 1990, The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins, Cell, 63, 851, 10.1016/0092-8674(90)90151-4

Barlow, 1995, Gametic imprinting in mammals, Science, 270, 1610, 10.1126/science.270.5242.1610

Benedict, 1983, Patient with 13 chromosome deletion, Science, 219, 973, 10.1126/science.6336308

Bernards, 1995, Flipping the Myc switch, Curr. Biol., 5, 859, 10.1016/S0960-9822(95)00173-4

Biegel, 1993, Constitutional 1p36 deletion in a child with neuroblastoma, Am. J. Hum. Genet., 52, 176

Brodeur, 1977, Chromosomal aberrations in human neuroblastomas, Cancer, 40, 2256, 10.1002/1097-0142(197711)40:5<2256::AID-CNCR2820400536>3.0.CO;2-1

Brodeur, 1984, Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage, Science, 224, 1121, 10.1126/science.6719137

Buchberg, 1990, Sequence homology shared by neurofibromatosis type-1 gene and IRA-1 and IRA-2 negative regulators of the RAS cyclic AMP pathway, Nature, 347, 291, 10.1038/347291a0

Caelles, 1994, p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes, Nature, 370, 220, 10.1038/370220a0

Caron, 1995, Evidence for two tumour suppressor loci on chromosomal bands 1p35–36 involved in neuroblastoma, Hum. Mol. Genet., 4, 535, 10.1093/hmg/4.4.535

Cavenee, 1983, Expression of recessive alleles by chromosomal mechanisms in retinoblastoma, Nature, 305, 779, 10.1038/305779a0

Cheng, 1995, Deletion mapping in neuroblastoma cell lines suggests two distinct tumor suppressor genes in the 1p35-36 region, only one of which is associated with N-myc amplification, Oncogene, 10, 291

Cheng, 1996, Human modifier of methylation for class I Hla genes (memo-1) maps to chromosomal bands 1p35–36.1, Hum. Mol. Genet., 5, 309, 10.1093/hmg/5.3.309

Davidoff, 1992, Expression of p53 in human neuroblastoma- and neuroepithelioma-derived cell lines, Oncogene, 7, 127

Donehower, 1992, Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours, Nature, 356, 215, 10.1038/356215a0

Dracopoli, 1989, Loss of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression, Proc. Natl. Acad. Sci. USA, 86, 4614, 10.1073/pnas.86.12.4614

El-Deiry, 1993, WAF1, a potential mediator of p53 tumor suppression, Cell, 75, 817, 10.1016/0092-8674(93)90500-P

Fearon, 1987, Clonal analysis of human colorectal tumors, Science, 238, 193, 10.1126/science.2889267

Genuardi, 1989, Distal deletion of chromosome Ip in ductal carcinoma of the breast, Am. J. Hum. Genet., 45, 73

Graeber, 1996, Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours, Nature, 379, 88, 10.1038/379088a0

Gyuris, 1993, Cdi1, a human G1 and S phase protein phosphatase that associates with Cdk2, Cell, 75, 791, 10.1016/0092-8674(93)90498-F

Hartwell, 1994, Cell cycle control and cancer, Science, 266, 1821, 10.1126/science.7997877

Heald, 1993, Human Wee1 maintains mitotic timing by protecting the nucleus from cytoplasmically activated cdc2 kinase, Cell, 74, 463, 10.1016/0092-8674(93)80048-J

Holland, 1996, Hox genes and chordate evolution, Dev. Biol., 173, 382, 10.1006/dbio.1996.0034

Hollstein, 1991, p53 mutations in human cancers, Science, 253, 49, 10.1126/science.1905840

Huttner, 1997, Asymmetric division and polarity of neuroepithelial cells, Curr. Opin. Neurobiol., 7, 29, 10.1016/S0959-4388(97)80117-1

Jacks, 1994, Tumor spectrum analysis in p53-mutant mice, Curr. Biol., 4, 1, 10.1016/S0960-9822(00)00002-6

Kastan, 1992, A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia, Cell, 71, 587, 10.1016/0092-8674(92)90593-2

Kessis, 1993, Human papilloma virus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage, Proc. Natl. Acad. Sci. USA, 90, 3988, 10.1073/pnas.90.9.3988

Kinzler, 1996, Life (and death) in a malignant tumour, Nature, 379, 19, 10.1038/379019a0

Knudson, 1980, Regression of neuroblastoma IV-S, New Eng. J. Med., 302, 1254, 10.1056/NEJM198005293022210

Ko, 1996, p53, Genes Dev., 10, 1054, 10.1101/gad.10.9.1054

Lane, 1979, T antigen is bound at a host protein in SV 40-transformed cells, Nature, 278, 261, 10.1038/278261a0

Laureys, 1995, Characterisation of the chromosome breakpoints in a patient with a constitutional translocation t(1;17)(p36.31;q11.2-q12) and neuroblastoma, Eur. J. Cancer, 31A, 523, 10.1016/0959-8049(95)00012-8

Levine, 1995, The spectrum of mutations at the p53 locus. Evidence for tissue-specific mutagenesis, selection of mutant alleles, and a “gain of function” phenotype, Ann. NY Acad. Sci., 768, 111, 10.1111/j.1749-6632.1995.tb12115.x

Li, 1969, Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome, ? Ann. Intern. Med., 71, 747, 10.7326/0003-4819-71-4-747

Lin, 1994, Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B-kD protein, Genes Dev., 8, 1235, 10.1101/gad.8.10.1235

Lin, 1994, Functions of the p53 protein in growth regulation and tumor suppression, CSH Sym. Quant. Biol., 59, 215, 10.1101/SQB.1994.059.01.026

Linzer, 1979, Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells, Cell, 17, 43, 10.1016/0092-8674(79)90293-9

Livingstone, 1992, Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53, Cell, 70, 923, 10.1016/0092-8674(92)90243-6

Lowe, 1993, p53 is required for radiation-induced apoptosis in mouse thymocytes, Nature, 362, 847, 10.1038/362847a0

Malkin, 1990, Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms, Science, 250, 1233, 10.1126/science.1978757

Maniatis, 1992

Moll, 1995, Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors, Proc. Natl. Acad. Sci. USA, 92, 4407, 10.1073/pnas.92.10.4407

Nigro, 1989, Mutations in p53 gene occur in diverse human tumour types, Nature, 342, 705, 10.1038/342705a0

Prats, 1989, High molecular mass forms of basic fibroblast growth factor are initiated by alternative CUG codons, Proc. Natl. Acad. Sci. USA, 86, 1836, 10.1073/pnas.86.6.1836

Ross, 1995, Human neuroblastoma I-type cells are malignant neural crest stem cells, Cell Growth Differ., 6, 449

Sozzi, 1988, Cytogenetic studies in primary and metastatic neuroendocrine Merkel cell carcinoma, Cancer Genet. Cytogenet., 30, 151, 10.1016/0165-4608(88)90104-5

Takeda, 1994, There may be two tumor suppressor genes on chromosome arm 1p closely associated with biologically distinct subtypes of neuroblastoma, Genes Chrom. Cancer, 10, 30, 10.1002/gcc.2870100106

Versteeg, 1995, 1p36, Eur. J. Cancer, 31A, 538, 10.1016/0959-8049(95)00037-J

Weinberg, 1993, Tumor suppressor genes, Neuron, 11, 191, 10.1016/0896-6273(93)90177-S

Werness, 1990, Association of human papillomavirus types 16 and 18 E6 proteins with p53, Science, 248, 76, 10.1126/science.2157286

White, 1995, A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2–36.3, Proc. Natl. Acad. Sci. USA, 92, 5520, 10.1073/pnas.92.12.5520

Yeh, 1994, Frequent genetic alterations at the distal region of chromosome 1p in human hepatocellular carcinomas, Cancer Res., 54, 4188

Zambetti, 1993, A comparison of the biological activities of wild-type and mutant p53, FASEB J., 7, 855, 10.1096/fasebj.7.10.8344485